CN1287844C - Pure Chinese medicine for treating infecundity, dysgenesia and mastopathia - Google Patents

Pure Chinese medicine for treating infecundity, dysgenesia and mastopathia Download PDF

Info

Publication number
CN1287844C
CN1287844C CN 200410036727 CN200410036727A CN1287844C CN 1287844 C CN1287844 C CN 1287844C CN 200410036727 CN200410036727 CN 200410036727 CN 200410036727 A CN200410036727 A CN 200410036727A CN 1287844 C CN1287844 C CN 1287844C
Authority
CN
China
Prior art keywords
portions
radix
root
rhizoma
fructus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 200410036727
Other languages
Chinese (zh)
Other versions
CN1569187A (en
Inventor
秦学彬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200410036727 priority Critical patent/CN1287844C/en
Publication of CN1569187A publication Critical patent/CN1569187A/en
Application granted granted Critical
Publication of CN1287844C publication Critical patent/CN1287844C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to pure traditional Chinese medicine for treating sterility and mastopathy. The present invention comprises two kinds of preparations, wherein one preparation is basically prepared from raw materials of the following proportion by weight: 5 to 9 portions of nutgrass galingale rhizome, 9 to 29 portions of red sage root, 5 to 9 portions of red peony root, 5 to 9 portions of radix paeoniae alba, 5 to 9 portions of peach seed, 5 to 9 portions of safflower, 2 to 5 portions of hemlock parsley, 5 to 12 portions of angelica, 5 to 12 portions of weeping forsythia capsule, 2 to 5 portions of fennel fruit, 5 to 9 portions of Chinese starjasmine stem, 2 to 5 portions of licorice root, 5 to 9 portions of rhizoma corydalis, 5 to 9 portions of cattail pollen, 5 to 9 portions of sparganium root, 5 to 9 portions of zedoray rhizome, 5 to 9 portions of common aucklandia root, 5 to 9 portions of dried tangerine peel, 5 to 9 portions of beautiful sweetgum fruit, 5 to 9 portions of hawthorn fruit, 5 to 9 portions of wolfberry bark and 2 to 5 portions of Chuan dipsacus root; the other preparation is basically composed of raw materials of the following proportion by weigh: 5 to 9 portions of nutgrass galingale rhizome, 9 to 29 portions of red sage root, 5 to 9 portions of red peony root, 5 to 9 portions of radix paeoniae alba, 5 to 9 portions of peach seed, 5 to 9 portions of safflower, 2 to 5 portions of hemlock parsley, 5 to 12 portions of angelica, 5 to 12 portions of weeping forsythia capsule, 2 to 5 portions of fennel fruit, 5 to 9 portions of Chinese starjasmine stem, 2 to 5 portions of licorice root, 5 to 9 portions of rhizoma corydalis, 5 to 9 portions of cattail pollen, 5 to 9 portions of sparganium root, 5 to 9 portions of zedoray rhizome, 5 to 9 portions of common aucklandia root, 5 to 9 portions of dried tangerine peel, 5 to 9 portions of beautiful sweetgum fruit, 5 to 9 portions of wolfberry bark, 4 to 17 portions of cortex moutan, 5 to 16.

Description

A kind of treatment barrenness and mastotic Chinese medicine medicine
One, technical field: the present invention relates to a kind of barrenness and mastotic Chinese medicine medicine of being used for the treatment of.
Two, background technology: at present, barrenness mostly is oviduct obstructive sterility, and salpingemphraxis hinders in collaterals of the uterus owing to gather, so that essence can not execute, and blood can not be taken the photograph, so do not wed and loss of fecundity.And the one-tenth of hernia abdominal mass, how because of in the miscarriage, the vessels of the uterus inanition, exopathogen is taken advantage of and is attacked, and being detained haunts, or internal damage by the excessive seven emotions, QI and blood is disorderly contrary, diet raw food, and ascending or descending movement of vital Qi is not normal, gas loses a surname's row, the stagnation of QI becomes the stasis of blood, hinder in sering, or invisible forming is gathered, therefore, the cause of disease of obstructive oviduct barrenness, pathogenesis should be qi depression to blood stasis.Since qi-blood disharmony, thus internal organs influenced, and particularly Liver and kidney two is dirty, and eight extra-channel is dashed wantonly two arteries and veins imbalance, so clinical common patient has depressed emotion, through the fore udder distending pain, face through inferior belly gas pain, through row piece is arranged, menoxenia or amenorrhea, symptoms such as ache of the spinal column, and in the majority with excess syndrome.The treatment means doctor trained in Western medicine is with hydrotubation or ventilation or uterine cavity injection treatment, though produce effect, undesirable.
Three, summary of the invention: the purpose of this invention is to provide a kind of treatment barrenness and mastotic Chinese medicine medicine of being specifically designed to.
The objective of the invention is to realize in the following manner:
Medicine of the present invention is made up of two parts, makes first's raw materials of effective components composition to be by weight: Rhizoma Cyperi 5-9 part, Radix Salviae Miltiorrhizae 9-29 part, Radix Paeoniae Rubra 5-9 part, Radix Paeoniae Alba 5-9 part, Semen Persicae 5-9 part, Flos Carthami 5-9 part, Rhizoma Chuanxiong 2-5 part, Radix Angelicae Sinensis 5-12 part, Fructus Forsythiae 5-12 part, Fructus Foeniculi 2-5 part, Caulis Trachelospermi 5-9 part, Radix Glycyrrhizae 2-5 part, Rhizoma Corydalis 5-9 part, Pollen Typhae 5-9 part, rhizoma sparganic 5-9 part, Rhizoma Curcumae 5-9 part, Radix Aucklandiae 5-9 part, Pericarpium Citri Reticulatae 5-9 part, Fructus Liquidambaris 5-9 part, Fructus Crataegi 5-9 part, Cortex Lycii 5-9 part, Radix Dipsaci 2-5 part;
Making second portion raw materials of effective components composition is by weight: Rhizoma Cyperi 5-9 part, Radix Salviae Miltiorrhizae 9-29 part, Radix Paeoniae Rubra 5-9 part, Radix Paeoniae Alba 5-9 part, Semen Persicae 5-9 part, Flos Carthami 5-9 part, Rhizoma Chuanxiong 2-5 part, Radix Angelicae Sinensis 5-12 part, Fructus Forsythiae 5-12 part, Fructus Foeniculi 2-5 part, Caulis Trachelospermi 5-9 part, Radix Glycyrrhizae 2-5 part, Rhizoma Corydalis 5-9 part, Pollen Typhae 5-9 part, rhizoma sparganic 5-9 part, Rhizoma Curcumae 5-9 part, Radix Aucklandiae 5-9 part, Pericarpium Citri Reticulatae 5-9 part, Fructus Liquidambaris 5-9 part, Cortex Lycii 5-9 part, Cortex Moutan 4-17 part, Radix Angelicae Dahuricae 5-16 part, Fructus Aurantii 5-9 part, Radix Glycyrrhizae 2-5 part, Squama Manis 1-3 part, Olibanum 3-10 part, Myrrha 3-10 part.
Its method for production is:
First's medicine is that various raw materials are concocted one by one, and pulverization mixes after crossing the 200-300 mesh sieve, makes powder or pill, and per 6 gram medicines are a bag.
The second portion medicine be with various raw materials one by one porphyrize mix after crossing the 200-300 mesh sieve, can be made into every content of dispersion is 450 milligrams of pills or capsule.
Advantage of the present invention is to have caught the cause of disease of barrenness and breast disease morbidity, follows doctor's ultimate principle, and the basic principle of determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs understanding disease and treatment disease is to the special research and the processing method of disease.Plan to implement the gasification stasis of blood, the removing food stagnancy block removing, QI and blood a surname row, Liver and kidney internal organs meridian function recovers naturally, and then tire is pregnant becomes, and lump in breast can disappear.With Drug therapy barrenness breast disease of the present invention have short treating period, cure rate can reach more than 85%, control the back and do not have advantages such as recurrence.
Four, the specific embodiment: with the raw material of following weight ratio: Rhizoma Cyperi 5-9 part, Radix Salviae Miltiorrhizae 9-29 part, Radix Paeoniae Rubra 5-9 part, Radix Paeoniae Alba 5-9 part, Semen Persicae 5-9 part, Flos Carthami 5-9 part, Rhizoma Chuanxiong 2-5 part, Radix Angelicae Sinensis 5-12 part, Fructus Forsythiae 5-12 part, Fructus Foeniculi 2-5 part, Caulis Trachelospermi 5-9 part, Radix Glycyrrhizae 2-5 part, Rhizoma Corydalis 5-9 part, Pollen Typhae 5-9 part, rhizoma sparganic 5-9 part, Rhizoma Curcumae 5-9 part, Radix Aucklandiae 5-9 part, Pericarpium Citri Reticulatae 5-9 part, Fructus Liquidambaris 5-9 part, Fructus Crataegi 5-9 part, Cortex Lycii 5-9 part, Radix Dipsaci 2-5 part, pill was made in mixing after pulverization was crossed the 200-300 mesh sieve, per 6 gram medicines are a bag, make first's medicine; Raw material with following weight ratio: Rhizoma Cyperi 5-9 part, Radix Salviae Miltiorrhizae 9-29 part, Radix Paeoniae Rubra 5-9 part, Radix Paeoniae Alba 5-9 part, Semen Persicae 5-9 part, Flos Carthami 5-9 part, Rhizoma Chuanxiong 2-5 part, Radix Angelicae Sinensis 5-12 part, Fructus Forsythiae 5-12 part, Fructus Foeniculi 2-5 part, Caulis Trachelospermi 5-9 part, Radix Glycyrrhizae 2-5 part, Rhizoma Corydalis 5-9 part, Pollen Typhae 5-9 part, rhizoma sparganic 5-9 part, Rhizoma Curcumae 5-9 part, Radix Aucklandiae 5-9 part, Pericarpium Citri Reticulatae 5-9 part, Fructus Liquidambaris 5-9 part, Cortex Lycii 5-9 part, Cortex Moutan 4-17 part, Radix Angelicae Dahuricae 5-16 part, Fructus Aurantii 5-9 part, Radix Glycyrrhizae 2-5 part, Squama Manis 1-3 part, Olibanum 3-10 part, Myrrha 3-10 part, porphyrize mixes after crossing the 200-300 mesh sieve one by one, makes every content of dispersion and be 450 milligrams capsule.Select oviduct obstructive sterility case 108 examples clinically, wherein 72 routine patients row hysterosalpingography or the cold shadow of uterus and fallopian tube Portugal amine radiographies, 36 customary tubal patent test by liquid instillation arts.In 72 example palace Salpingography cases, matter portion blocks 8 examples between the fallopian tube bilateral, and the bilateral isthmus blocks 17 examples, and the bilateral ampulla blocks 16 examples, and bilateral umbrella portion blocks 23 examples, and each one is mixed and hydrosalpinx 8 examples.Take medicine of the present invention for above-mentioned case, its usage is: 30 days is a course of treatment, at first first's medicine is taken twice every day, and (medicine) being taken before meal was obeyed 15 days with each bag, obeyed the second portion medicine again in later 15 days, every day twice, each 6-8 grain.Take medicine and carry out Salpingography or logical liquid after a course of treatment, the nonresponder is obeyed one to two course of treatment again.Its therapeutic outcome is most patients fruits that promptly take effect one to two course of treatment of taking medicine, and total effective 98 examples account for 89.8%, the rate 85.2% of recovering; Wherein pregnant 22 people, pregnancy rate 20.4%; Invalid 11 examples, inefficiency 10.2%.Because of 8 examples of not ovulating in total effectively case, bad 12 examples of luteal function, dysspermatism 16 examples in the bridegroom's or husband's side are so obviously influenced pregnancy rate.108 routine patients from administration, medicine of the present invention shows as the effect of isolated uterine, fallopian tube smooth muscle can make uterus, fallopian tube smooth muscle relaxation, this helps the elimination of salpingitis tubal and the reparation of tissue, help the elimination and the absorption of foreign body in the fallopian tube, thereby help oviducal unimpeded.In addition, the salpingitis tubal patient often with the clinical manifestation of abdominal discomfort or pain, this lax uterus of medicine of the present invention, the effect of fallopian tube smooth muscle can help the alleviation of patient's clinical symptoms.
Below provide three model cases of the present invention:
Case 1 Zhao so-and-so, the woman, 33 years old, in calendar year 2001 first visit on April 26, the 6 years unpregnancies of marrying.Menoxenia is faced through lower abdominal distention pain, through the fore udder distending pain, susceptible to lose temper due to restlessness, the amount of passing through polychrome is red, edema of lower limbs, leucorrhea with yellow discharge usually, the thick amount of matter is many, stringy and thready pulse, thin fur matter is dim red, gynecologial examination, and vagina is smooth, cervix uteri is gently rotten, palace body hypsokinesis, normal size adnexa feminine gender, hysterosalpingography, the bilateral salpingitis, umbrella end completeness is blocked.Take medicine of the present invention after one 30 days courses of treatment, look into Salpingography again, the bilateral fallopian tube is unobstructed, and the main suit spends more than 10 day and do not go menstrual period, cold physique occurs, plays symptoms such as cold evil morning, and the test of urine very early pregnancy is positive.
Case 2 week so-and-so, the woman, 28 years old, the teacher, the 7 years unpregnancies of marrying, husband's seminal fluid is conventional normal, first visit on January 4 in 2002, Salpingography, the obstruction of bilateral fallopian tube adhesion.Gynecologial examination: the bilateral adnexa increases that thick tenderness is obvious, and the uterus is slightly little, thready and rapid pulse, and the dim tongue of body of the tongue is few, irregular menstruation, front and back are indefinite, clot, breast swell and pain.After course of therapy of medicine of the present invention, pertubation, this moment is logical and not smooth, obey a course of treatment again after, Salpingography is unimpeded fully, in further consultation on May 8 in 2002, the very early pregnancy test was become pregnant.
Case 3 grandsons so-and-so, the woman, 29 years old, the cadre, first visit in April, 2003 is because of the housework dispute, inability of coition is arranged, spirit depressing, it is fixed not have menstrual period, row and not walking, wed 3 years infertile, the preceding susceptible to lose temper due to restlessness of menstrual onset, insomnia and dreamful sleep, distending pain of the breast, the time sore nipples is arranged, can not touch clothing, piece is arranged.With the diagnosis of infrared ray mammary gland instrument, cyclomastopathy is arranged.Lower abdomen is had a pain and is stirred thorn as club when passing through, and blood is black piece, and stringy pulse tongue limit one side has several somes ecchymosis, and disorder of QI is with the passing of time, strongly fragrantly must return liver, qi depression to blood stasis, and cause infertile, invalid through multi-treatment in the past.Come this with medicine of the present invention after 2 courses of treatment, cyclomastopathy and other are normal, ask to know and become pregnant after in October, 2003.

Claims (1)

1, a kind of treatment barrenness and mastotic Chinese medicine medicine, it is characterized in that: this medicine is made up of two parts, makes first's raw materials of effective components composition to be by weight: Rhizoma Cyperi 5-9 part, Radix Salviae Miltiorrhizae 9-29 part, Radix Paeoniae Rubra 5-9 part, Radix Paeoniae Alba 5-9 part, Semen Persicae 5-9 part, Flos Carthami 5-9 part, Rhizoma Chuanxiong 2-5 part, Radix Angelicae Sinensis 5-12 part, Fructus Forsythiae 5-12 part, Fructus Foeniculi 2-5 part, Caulis Trachelospermi 5-9 part, Radix Glycyrrhizae 2-5 part, Rhizoma Corydalis 5-9 part, Pollen Typhae 5-9 part, rhizoma sparganic 5-9 part, Rhizoma Curcumae 5-9 part, Radix Aucklandiae 5-9 part, Pericarpium Citri Reticulatae 5-9 part, Fructus Liquidambaris 5-9 part, Fructus Crataegi 5-9 part, Cortex Lycii 5-9 part, Radix Dipsaci 2-5 part;
Making second portion raw materials of effective components composition is by weight: Rhizoma Cyperi 5-9 part, Radix Salviae Miltiorrhizae 9-29 part, Radix Paeoniae Rubra 5-9 part, Radix Paeoniae Alba 5-9 part, Semen Persicae 5-9 part, Flos Carthami 5-9 part, Rhizoma Chuanxiong 2-5 part, Radix Angelicae Sinensis 5-12 part, Fructus Forsythiae 5-12 part, Fructus Foeniculi 2-5 part, Caulis Trachelospermi 5-9 part, Radix Glycyrrhizae 2-5 part, Rhizoma Corydalis 5-9 part, Pollen Typhae 5-9 part, rhizoma sparganic 5-9 part, Rhizoma Curcumae 5-9 part, Radix Aucklandiae 5-9 part, Pericarpium Citri Reticulatae 5-9 part, Fructus Liquidambaris 5-9 part, Cortex Lycii 5-9 part, Cortex Moutan 4-17 part, Radix Angelicae Dahuricae 5-16 part, Fructus Aurantii 5-9 part, Radix Glycyrrhizae 2-5 part, Squama Manis 1-3 part, Olibanum 3-10 part, Myrrha 3-10 part.
CN 200410036727 2004-04-27 2004-04-27 Pure Chinese medicine for treating infecundity, dysgenesia and mastopathia Expired - Fee Related CN1287844C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200410036727 CN1287844C (en) 2004-04-27 2004-04-27 Pure Chinese medicine for treating infecundity, dysgenesia and mastopathia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200410036727 CN1287844C (en) 2004-04-27 2004-04-27 Pure Chinese medicine for treating infecundity, dysgenesia and mastopathia

Publications (2)

Publication Number Publication Date
CN1569187A CN1569187A (en) 2005-01-26
CN1287844C true CN1287844C (en) 2006-12-06

Family

ID=34481578

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200410036727 Expired - Fee Related CN1287844C (en) 2004-04-27 2004-04-27 Pure Chinese medicine for treating infecundity, dysgenesia and mastopathia

Country Status (1)

Country Link
CN (1) CN1287844C (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101138588B (en) * 2006-09-08 2010-09-08 山东轩竹医药科技有限公司 Pharmaceutical composition for treating gland hyperplasia and method of preparing the same
CN101199782B (en) * 2007-12-17 2010-06-02 席凤英 Chinese medicine composition of oral administration for treating irregular menstruation
CN101816737B (en) * 2010-05-27 2011-08-24 田玄章 Chinese medicinal preparation for treating infertility
CN102641476B (en) * 2012-05-07 2013-11-06 韩德礼 Traditional Chinese medicine preparation for treating infertility
CN104116796B (en) * 2014-08-12 2016-03-09 李海英 A kind of pharmaceutical composition for the treatment of cyclomastopathy

Also Published As

Publication number Publication date
CN1569187A (en) 2005-01-26

Similar Documents

Publication Publication Date Title
CN101816776B (en) Chinese medicinal composition for treating delayed menstrual cycle delayed menstrual cycledelayed menstrual cycle and preparation method thereof
CN101966322A (en) Traditional Chinese medicinal composition for treating ovarian cyst and preparation method thereof
CN101780254B (en) Traditional Chinese medicine compound for treating intestinal tumor
CN101342353A (en) Traditional Chinese medicine preparation for treating barrenness and preparation method thereof
CN103585378A (en) A Chinese medicinal composition for treating female infertility, and its preparation method
CN104922543A (en) Medicine composite for treating amenorrhea and preparation method thereof
CN104208554A (en) Traditional Chinese medicine mainly for treating multiple female diseases
CN101085301A (en) Oral administration traditional Chinese medicine composition for treating mammary cancer
CN104922613A (en) Medicine composite for treating sterility and preparation method thereof
CN109528980A (en) A kind of Chinese medicine composition and its pharmacy application for treating Ovary reserve decline disease
CN103948782B (en) Pharmaceutical composition for treating hyperplasia of mammary glands due to stagnation of liver qi as well as preparation method and application of pharmaceutical composition
CN1287844C (en) Pure Chinese medicine for treating infecundity, dysgenesia and mastopathia
CN100333782C (en) Female nutritive tonic capsule
CN106177807A (en) A kind of Chinese medicine formula treating breast carcinoma
CN1879838A (en) A Chinese medicine for treating threatened abortion
CN102343019B (en) Chinese medicinal composition for treating amenorrhea and preparation method of preparation thereof
CN103638456A (en) Traditional Chinese medicine for treating liver cirrhosis and preparation method for same
CN106421603A (en) Medicine for treating cardiovascular disease and preparation method thereof
CN105497262A (en) Medicine composition for treating liver-yin and kidney-yin deficiency type polycystic ovarian syndrome
CN105833209B (en) Traditional Chinese medicine composition for treating endometriosis
CN106389557B (en) A kind of Chinese medicine composition and its preparation method and application for Chinese medicine moxibustion
CN105853659B (en) Traditional Chinese medicine composition for treating polycystic ovarian syndrome
CN1081063C (en) Fetus-protecting instant particles for treating habitual or threatened abortion
CN100377739C (en) Gynecopathy treating medicine and its prepn process
CN105535199A (en) Pharmaceutical preparation for treating polycystic ovarian syndromes accompanied with mammary gland hyperplasia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee